RadNet, Inc.
RDNT Healthcare Diagnostics & Research
RadNet, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 11.5% from fiscal 2024.
- Revenue
- +25.0%
- EPS
- −47.4%
- Free cash flow
- −43.2%
- Total debt
- +21.2%
Quarter to June 2026, against a year earlier
Follow RDNT
Alert me
RadNet, Inc. (RDNT) valuation and DCF model
At $77.13 the price implies free cash flow after share-based pay growing 48.7% a year for ten years.
Free cash flow after share-based pay grew 0.5% a year over the last ten years, −18.9% over the last five. The price asks for more than four times its ten-year rate. The industry’s median company is priced for 15.8%.
In December 2017 the price assumed 7.1% a year; RadNet, Inc. went on to grow free cash flow after share-based pay −10.1% a year to FY2025.
- The price needs
- 48.7% a year for ten years
- $77.13
- today’s price
Base case on its own ten-year record RadNet, Inc.’s own growth, carried forward
Its assumptions
Powerpack lets you start from a scenario and type over any of them.
How we got there$98.87m 10 years of cash to equity+$104.46m terminal value−$579.88m net debt=$(376.55m) equity value÷77.09m shares=$(4.88) per share
Valuation against its own history
| Multiple | Current | 5Y avg | 10Y avg | vs 10Y avg | Industry median | vs industry | 10Y range |
|---|---|---|---|---|---|---|---|
| P/E | — | 1,204.32× | 867.70× | — | 34.52× | — | |
| P/FCF | 188.87× | 594.09× | 315.49× | 40% below | 33.51× | 464% above | |
| P/B | 4.38× | 3.53× | 3.96× | 11% above | 3.42× | 28% above | |
| EV/EBITDA | 21.80× | 15.24× | 11.95× | 82% above | 23.44× | 7% below | |
| EV/Sales | 2.96× | 2.33× | 1.86× | 59% above | 5.18× | 43% below |
P/E has no reading today; its 10-year average is 867.70×.